sulfinpyrazone has been researched along with Kidney Diseases in 21 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary heart disease is the leading cause of death in the gouty and nongouty population." | 1.26 | Changing trends of mortality in gout. ( Talbott, JH; Yü, T, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BERGAMINI, A | 1 |
| VENTURA, E | 1 |
| TREADWELL, B | 1 |
| REAH, TG | 1 |
| Morin, RJ | 1 |
| Chen, AF | 1 |
| Narayanan, AS | 1 |
| Raye, C | 1 |
| Moss, RA | 1 |
| Srikantaiah, MV | 1 |
| Barajas, L | 1 |
| Birgens, HS | 1 |
| Hansen, MS | 1 |
| Butler, AL | 1 |
| Boelaert, J | 1 |
| Van Eeghem, P | 1 |
| Daneels, R | 1 |
| Schurgers, M | 1 |
| Fagard, R | 1 |
| Lijnen, P | 1 |
| Verschueren, LJ | 1 |
| Amery, A | 1 |
| Yü, T | 1 |
| Talbott, JH | 1 |
| Rubegni, M | 1 |
| Provvedi, D | 1 |
| Bellini, PG | 1 |
| Bandinelli, C | 1 |
| De Mauro, G | 1 |
| George, CR | 1 |
| Clark, WF | 1 |
| Cameron, JS | 1 |
| Harker, LA | 1 |
| Hirsh, J | 1 |
| Gent, M | 1 |
| Genton, E | 1 |
| Weiss, HJ | 1 |
| Klinenberg, JR | 1 |
| Bluestone, R | 1 |
| Campion, D | 1 |
| Whitehouse, M | 1 |
| Gutman, AB | 1 |
| Klotz, H | 1 |
| Prohaska, E | 1 |
| Salmhofer, H | 1 |
| Schmid, L | 1 |
| Günther, R | 1 |
| Knapp, E | 1 |
| Kersley, GD | 1 |
| Riccitelli, ML | 1 |
| Holländer, E | 1 |
| Schwarczmann, P | 1 |
| Ogryzlo, MA | 1 |
| Urowitz, MB | 1 |
| Weber, HM | 1 |
| Houpt, JB | 1 |
| Schirmeister, J | 1 |
| Stefani, F | 1 |
| Willmann, H | 1 |
| Hallauer, W | 1 |
4 reviews available for sulfinpyrazone and Kidney Diseases
| Article | Year |
|---|---|
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
The role of platelets in glomerulonephritis.
Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium; | 1975 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi | 1976 |
1 trial available for sulfinpyrazone and Kidney Diseases
| Article | Year |
|---|---|
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
17 other studies available for sulfinpyrazone and Kidney Diseases
| Article | Year |
|---|---|
[Sulfinpyrazone in juvenile polyarticular gout. Reversible obstructive tubulonephrosis as an early complication of effective uricosuric treatment].
Topics: Gout; Humans; Hyperuricemia; Kidney Diseases; Sulfinpyrazone; Sulfonamides | 1962 |
THE TREATMENT OF GOUT.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Colchicine; Diet; Diet Therapy; Dr | 1964 |
GOUT.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Colchicine; Diagnosis, Differential; Diet; Diet | 1964 |
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; K | 1980 |
Renal dysfunction due to anturane.
Topics: Humans; Kidney Diseases; Male; Middle Aged; Sulfinpyrazone | 1981 |
Renal dysfunction due to anturane.
Topics: Double-Blind Method; Humans; Kidney Diseases; Sulfinpyrazone | 1981 |
Changing trends of mortality in gout.
Topics: Aged; Arteriosclerosis; Coronary Disease; Female; Gout; Humans; Kidney Diseases; Male; Middle Aged; | 1980 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso | 1975 |
The binding of urate to plasma proteins.
Topics: Allopurinol; Aspirin; Binding Sites; Blood Proteins; Colchicine; Dialysis; Evaluation Studies as Top | 1974 |
Medical management of gout.
Topics: Adult; Allopurinol; Colchicine; Diet Therapy; Female; Gout; Humans; Kidney Diseases; Male; Middle Ag | 1972 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Com | 1971 |
[Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
Topics: Allopurinol; Diabetes Mellitus; Gout; Humans; Hypertension; Kidney Diseases; Male; Sulfinpyrazone; U | 1969 |
Long-term use of allopurinol in the treatment of gout.
Topics: Adolescent; Aged; Allopurinol; Colic; Female; Gout; Humans; Kidney Diseases; Male; Middle Aged; Sulf | 1970 |
Etiology and treatment of gout--modern concepts.
Topics: Allopurinol; Colchicine; Crystallization; Diagnosis, Differential; Diet Therapy; Gout; Humans; Indom | 1968 |
[Gout in advanced age].
Topics: Age Factors; Aged; Allopurinol; Bone and Bones; Cardiovascular Diseases; Colchicine; Female; Gout; H | 1968 |
Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
Topics: Allopurinol; Blood Urea Nitrogen; Enzyme Therapy; Female; Gout; Humans; Kidney Calculi; Kidney Disea | 1966 |
[Intrarenal nitrofurantoin transport in man].
Topics: Adolescent; Adult; Aminohippuric Acids; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney | 1966 |